Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice

被引:60
作者
Afek, A
George, J
Shoenfeld, Y [1 ]
Gilburd, B
Levy, Y
Shaish, A
Keren, P
Janackovic, Z
Goldberg, I
Kopolovic, J
Harats, D
机构
[1] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Med B,Res Inst Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Inst Pathol, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Inst Lipid & Atherosclerosis Res, IL-52621 Tel Hashomer, Israel
关键词
atherosclerosis; beta(2)-glycoprotein I; anticardiolipin antibodies; low density lipoprotein; oxidized; apolipoprotein E-deficient mice;
D O I
10.1159/000028046
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously shown that low density lipoprotein receptor-deficient (LDL-RD) mice immunized with beta(2)-glycoprotein I (beta 2GPI; a target of autoimmune anticardiolipin antibodies) developed enhanced early atherosclerosis, when fed a normal chow diet. The current study was undertaken to evaluate the effect of immunization with beta 2GPI and the addition of a high fat diet on the progression of atherosclerosis in the apolipoprotein E (ApoE)deficient mouse. Six-week-old female ApoE-deficient mice (n = 10) were immunized subcutaneously with either human beta 2GPI or with ovalbumin, both emulsified in complete Freund's adjuvant and fed a high fat diet for 6 weeks. The beta 2GPI-immunized mice were found to develop accelerated atherosclerosis when compared with their ovalbumin-immunized littermates (aortic lesion area of 137,500 +/- 13,801 vs. 72,444 +/- 14,465 mu m(2), respectively; p = 0.0067). The beta 2GPI-immunized mice developed high liters of anti-beta 2GPI antibodies, 10 days after the procedure, which were sustained until the sacrifice. LDL extracted from both study groups displayed similar susceptibility to ex vivo oxidation. These results confirm our previous study in which we found increased atherosclerosis in beta 2GPI-immunized LDL-RD mice fed a chow diet. In the current study we show that the proatherogenic effect of beta 2GPI immunization is maintained despite high cholesterol levels and is not associated with increased susceptibility of LDL to ex vivo oxidation.
引用
收藏
页码:19 / 25
页数:7
相关论文
共 42 条
[1]   Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits [J].
Ameli, S ;
HultgardhNilsson, A ;
Regnstrom, J ;
Calara, F ;
Yano, J ;
Cercek, B ;
Shah, PK ;
Nilsson, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) :1074-1079
[2]  
ARON AL, 1995, CLIN EXP IMMUNOL, V101, P78
[3]   IMMUNIZATION WITH ANTICARDIOLIPIN COFACTOR (BETA-2-GLYCOPROTEIN-I) INDUCES EXPERIMENTAL ANTIPHOSPHOLIPID SYNDROME IN NAIVE MICE [J].
BLANK, M ;
FADEN, D ;
TINCANI, A ;
KOPOLOVIC, J ;
GOLDBERG, I ;
GILBURD, B ;
ALLEGRI, F ;
BALESTRIERI, G ;
VALESINI, G ;
SHOENFELD, Y .
JOURNAL OF AUTOIMMUNITY, 1994, 7 (04) :441-455
[4]  
CABRAL AR, 1995, J RHEUMATOL, V22, P1894
[5]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[6]  
Ferro D, 1997, CIRCULATION, V95, P1425
[7]  
Garcia CO, 1996, J INVEST MED, V44, pA69
[8]   Differential effects of anti-β2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome [J].
George, J ;
Blank, M ;
Levy, Y ;
Meroni, P ;
Damianovich, M ;
Tincani, A ;
Shoenfeld, Y .
CIRCULATION, 1998, 97 (09) :900-906
[9]   Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies [J].
George, J ;
Afek, A ;
Gilburd, B ;
Levy, Y ;
Blank, M ;
Kopolovic, J ;
Harats, D ;
Shoenfeld, Y .
LUPUS, 1997, 6 (09) :723-729
[10]   Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS) [J].
George, J ;
Blank, M ;
Hojnik, M ;
BarMeir, E ;
Koike, T ;
Matsuura, E ;
Lorber, M ;
Aviram, M ;
Shoenfeld, Y .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (02) :227-233